Biotech

All Articles

Lilly, Haya ink $1B biobuck weight problems pact to browse black genome

.Eli Lilly's search for weight problems intendeds has actually led it to the black genome. The Big P...

ArsenalBio elevates $325M, pivots off of past lead resource

.Arsenal Biosciences is actually carrying on up. The tissue treatment company has actually added on ...

Lilly- backed fat loss biotech data IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has submitte...

Aelis' marijuana use medication fails period 2b, steering Indivior to rethink $100M option

.Aelis Farma's hopes of protecting a simple, favorable selection on a $100 million alternative payme...

ProKidney halts stage 3 trial not needed to have for tissue therapy approval

.ProKidney has actually stopped some of a pair of period 3 tests for its own tissue treatment for re...

Vaxcyte rises on 'magnificent' 31-valent PCV gain versus Pfizer

.Vaxcyte unveiled what analysts named "impressive" phase 1/2 information for its 31-valent pneumococ...

Recursion's human brain condition test presents scant proof of efficiency

.Recursion has discovered via a very early examination of its own tech-enabled method to medication ...

Acepodia, Pfizer click all together for chemistry-based cell treatment

.Call it an instance of good chemistry: Acepodia, a biotech based upon Nobel Champion scientific res...

Praxis epilepsy medicine minimizes seizures in stage 2 hearing

.Practice Accuracy Medicines has actually scored an additional midphase gain in epilepsy this year, ...

Three execs resign as Dyne blog posts blended records for DMD prospect

.After escaping a professional grip several years back, Dyne Rehab has revealed brand-new stage 1/2 ...